Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year

Thursday, June 5, 2025

BioNTech and Bristol Myers Squibb Launch Global Partnership to Develop Innovative Cancer Therapies with BNT327

BioNTech SE and Bristol Myers Squibb announced a major global strategic partnership. Together, they will co-develop and commercialize the bispecific antibody candidate BNT327 to treat a wide range of solid tumors.

BNT327 is an advanced-stage clinical immunotherapy candidate that combines two validated mechanisms into a single molecule: PD-L1 checkpoint inhibition and VEGF-A neutralization. This innovative approach aims to provide new treatment options for patients with hard-to-treat cancers.

The partnership is based on a 50:50 profit and loss split, covering both clinical development and potential commercialization. Over 20 studies are already underway or in preparation, including global Phase 3 trials for small cell and non-small cell lung cancer, as well as triple-negative breast cancer (TNBC).

"BNT327 could become a cornerstone of immuno-oncology," said Prof. Ugur Sahin, CEO of BioNTech. Christopher Boerner, CEO of Bristol Myers Squibb, added: “Together, we have the potential to fundamentally change the standard of care for solid tumors.”

Under the agreement, BMS will make an upfront payment of $1.5 billion to BioNTech, in addition to up to $7.6 billion in potential milestone payments. Both companies retain the right to independently develop BNT327 in other indications and combinations, including assets from their own pipelines.

BNT327 enhances the companies' positions as leaders in immuno-oncology. By targeting the tumor microenvironment, the therapy aims not only to halt tumor growth but also to boost the immune system’s response – a potential turning point in cancer treatment.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.